Pre-emption and States' Rights
Pharma backs federal standards for compassionate use, drug importing, data transparency, and track-and-trace. Jill Wechsler reports.
FDA Abroad
FDA officials willing to relocate to far-flung global cities should be congratulated for their herculean efforts to protect American patients. But funding cuts hamper the Agency's international presence.
Vaccines: Fire in the Cold Chain
Its only recently that vaccine producers experienced the commercial returns commensurate with vaccines: long record of positive public health performance.
Pharm Exec's 2014 Dealmakers Outlook
As the pacing picks up around dealmaking as the alternative to organic growth, Pharm Exec brings together experts from big Pharma and biotech to dissect the road ahead for M&A, licensing, and partnership activity.
The Peace Dividend
A surprising takeaway from the recent BIO Convention, writes William Looney, is the stark contrast between cooperative industry engagement and an unstable geopolitical order.
Country Report: Poland
Poland's pharma industry, the largest in Central and Eastern Europe, confronts the fallout from the government's controversial 2012 Reimbursement Act.
Europe Gears Up to Attack Counterfeit Medicines—But Only Some of Them
Cross-sector partnership seeks support for a pan-European system to keep fake drugs out, but obstacles are many.
